Results 211 to 220 of about 230,788 (365)
The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approaches
ESC Heart Failure, EarlyView.Nrf2 signalling is impaired in heart failure, contributing to oxidative stress, mitochondrial dysfunction, and ferroptosis, which drive neurohormonal activation, inflammation, and ischaemia‐reperfusion injury. This loss of Nrf2 activity exacerbates hypertension, diabetic cardiomyopathy, and cardiotoxicity, accelerating progression to overt heart ...
Emiliano Fiori +9 more
wiley +1 more source
An Atypical Presentation of ST-Segment Elevation Myocardial Infarction in a 30-Year-Old Male Patient: A Case Report. [PDF]
CureusBandey W, Begum R, Khan M, Davis T.
europepmc +1 more source
Identification of multiple variants of fast muscle troponin T in the chicken using monoclonal antibodies [PDF]
, 1985 Ian M. Bird +2 more
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra +25 more
wiley +1 more source
The Utility of Troponin in Predicting Cardiac Dysfunction in Pediatric Patients: A Meta-Analysis. [PDF]
CureusKadakia R +7 more
europepmc +1 more source
ESC Heart Failure, EarlyView.The aim of our study was to develop a more accurate staging system for hereditary ATTR patients currently receiving specific treatment. A staging system was created using as criteria: GLS ≤ −11%, NT‐proBNP ≤ 2,000 ng/L, and eGFR ≤ 65 mL/min. We managed to accurately stratify patients into three disease stages, significantly different in terms of ...
Gabriela Neculae +7 more
wiley +1 more source
Estimation of Cardiac Troponin-T Levels in Acute Myocardial Infarction With Reference to Short-Term Prognosis. [PDF]
CureusMolugu SVR +3 more
europepmc +1 more source
Investigation of cation-binding properties of cardiac troponin C peptides by circular-dichroism spectroscopy [PDF]
, 1984 Nikolai B. Gusev, N V Barskaya
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller +12 more
wiley +1 more source